SEI Investments’s Dova Pharmaceuticals, Inc. Common Stock DOVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
– Sell
-20,956
Closed -$586K – 2501
2019
Q3
$586K Buy
+20,956
New +$340K ﹤0.01% 1811
2018
Q2
– Sell
-89
Closed -$2K – 3909
2018
Q1
$2K Hold
89
– – ﹤0.01% 3291
2017
Q4
$3K Buy
+89
New +$2.44K ﹤0.01% 3085

SEI Investments's DOVA Position: Q4 2019 in Review

SEI Investments sold out of Dova Pharmaceuticals, Inc. Common Stock (DOVA) in Q4 2019, closing a stake of 20,956 shares — an estimated $586K sold.

SEI Investments first reported a position in DOVA in Q4 2017 and held it in 3 quarters. The position peaked at $586K in Q3 2019. 0 funds tracked by Wall St. Rank hold DOVA as of Q4 2019.

  • SEI Investments reported no remaining Dova Pharmaceuticals, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
  • SEI Investments sold 20,956 Dova Pharmaceuticals, Inc. Common Stock shares in Q4 2019, an estimated $586K.
  • SEI Investments first reported a position in Dova Pharmaceuticals, Inc. Common Stock in Q4 2017 and held it in 3 quarters.
  • SEI Investments's Dova Pharmaceuticals, Inc. Common Stock position peaked at $586K in Q3 2019.
  • 0 funds tracked by Wall St. Rank held Dova Pharmaceuticals, Inc. Common Stock as of Q4 2019.

Based on SEI Investments's 13F filing for Q4 2019, filed 6 Feb 2020.